Ignite Creation Date:
2025-12-24 @ 3:06 PM
Ignite Modification Date:
2026-02-23 @ 12:22 PM
Study NCT ID:
NCT00468559
Status:
COMPLETED
Last Update Posted:
2014-06-02
First Post:
2007-04-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 3/Safety & Efficacy of Esomeprazole in Infants
Sponsor:
AstraZeneca
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
D9614C00096
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None